These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 404303)

  • 1. Cell density-dependent secretion of plasminogen activator by 3T3 cells.
    Chou IN; O'Donnell SP; Black PH; Roblin RO
    J Cell Physiol; 1977 Apr; 91(1):31-7. PubMed ID: 404303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
    Rosenthal SL; Zucker D; Davidson RL
    J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
    Del Rosso M; Dini G; Fibbi G
    Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium stimulation of plasminogen activator secretion/production by swiss 3T3 cells.
    Chou IN; Roblin RO; Black PH
    J Biol Chem; 1977 Sep; 252(18):6256-9. PubMed ID: 197085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in intracellular distribution of plasminogen activator in growing, confluent, and transformed 3T3 cells.
    Jaken S; Black PH
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):246-50. PubMed ID: 284339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells.
    Topp W; Hall JD; Marsden M; Teresky AK; Rifkin D; Levine AJ; Pollack R
    Cancer Res; 1976 Nov; 36(11 Pt. 2):4217-23. PubMed ID: 184930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium transport in normal and transformed mouse 3T3 cells.
    Spaggiare S; Wallach MJ; Tupper JT
    J Cell Physiol; 1976 Nov; 89(3):403-16. PubMed ID: 977660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic activity and plasminogen activator in harvest fluid concentrates from mammary cells in culture.
    Howard EF; Cheng CY; Howard JS
    Cancer Res; 1980 Dec; 40(12):4385-9. PubMed ID: 7192175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of retinoic acid on plasminogen activator and mitogenic responses of cultured mouse cells.
    Schroder EW; Chou IN; Black PH
    Cancer Res; 1980 Sep; 40(9):3089-94. PubMed ID: 6253054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in pattern and level of plasminogen activator production between a cloned cell line from an ethylnitrosourea-induced glioma and one from normal adult rat brain.
    Hince TA; Roscoe JP
    J Cell Physiol; 1980 Aug; 104(2):199-207. PubMed ID: 7190976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
    Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high level of cell surface phosphatidylinositol-specific phospholipase C activity is characteristic of growth-arrested 3T3 fibroblasts but not of transformed variants.
    Volwerk JJ; Birrell GB; Hedberg KK; Griffith OH
    J Cell Physiol; 1992 Jun; 151(3):613-22. PubMed ID: 1338336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-cell contact and growth regulation of pinocytosis in 3T3 cells.
    Davies PF
    J Supramol Struct; 1980; 13(2):211-7. PubMed ID: 6264231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro plasminogen activator activity in human brain tumors.
    Tucker WS; Kirsch WM; Martinez-Hernandez A; Fink LM
    Cancer Res; 1978 Feb; 38(2):297-302. PubMed ID: 620402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusible factor(s) controlling density inhibition of 3T3 cell growth: a new approach.
    Harel L; Jullien M; de Monti M
    J Cell Physiol; 1978 Sep; 96(3):327-32. PubMed ID: 670314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of 6-deoxy-D-glucose and D-xylose by untransformed and SV40-transformed 3T3 cells.
    Romano AH; Connell ND
    J Cell Physiol; 1982 Apr; 111(1):83-8. PubMed ID: 6282906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of plasminogen activator by cells transformed by herpesviruses.
    Howett MK; High CS; Rapp F
    Cancer Res; 1978 Apr; 38(4):1075-8. PubMed ID: 205345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cellular density and viral oncogenes on the major histocompatibility complex class I antigen response to gamma-interferon in BALB-c/3T3 cells.
    Offermann MK; Faller DV
    Cancer Res; 1990 Feb; 50(3):601-5. PubMed ID: 2105158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.
    Jankun J; Maher VM; McCormick JJ
    Cancer Res; 1991 Feb; 51(4):1221-6. PubMed ID: 1847659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator: the major secreted neutral protease of cultured skeletal muscle cells.
    Festoff BW; Patterson MR; Romstedt K
    J Cell Physiol; 1982 Feb; 110(2):190-5. PubMed ID: 7040426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.